Industries - Amyotrophic Lateral Sclerosis Treatment Market Analysis by Treatment (Stem Cell Transplant, Medication), by Distribution Channel (Hospitals, Retail Pharmacies) and by Region – Forecast to 2025

Ablation Technology Market Analysis

Amyotrophic Lateral Sclerosis Treatment Market Analysis by Treatment (Stem Cell Transplant, Medication), by Distribution Channel (Hospitals, Retail Pharmacies) and by Region – Forecast to 2025
October 2020

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Amyotrophic Lateral Sclerosis Treatment Market Analysis by Treatment (Stem Cell Transplant, Medication), by Distribution Channel (Hospitals, Retail Pharmacies) and by Region - Forecast to 2025

Published: October 2020 | Historical Data: 2017-2019 | Base Year: 2019
SKU: ICI-HC-1012 | Number of Pages: 128 | Category: Pharmaceuticals

The global amyotrophic lateral sclerosis (ALS) treatment market size is estimated to be USD 625.0 million in 2019 and is expected to witness a CAGR of 6.9% during the forecast period. Increasing geriatric population globally, rising awareness of ALS, and growing incidence of ALS are some of the key factors boosting growth of the global market. However, high cost related with ALS treatment is expected to hinder the market growth during the forecast period.

Amyotrophic Lateral Sclerosis Treatment Market

By Treatment

Based on treatment, the amyotrophic lateral sclerosis treatment market is segmented into stem cell therapies, medications, and others. In 2019, the medications segment was the highest revenue-grossing segment owing to approval of two major drugs including Rilutek (riluzole) and Radicava (edaravone) by the U.S. FDA. However, the stem cell therapies segment is expected to grow at a fastest CAGR during the forecast period. This is attributed to the rising demand for advanced treatment alternatives and new approaches for the management of ALS.

By Distribution Channel

Based on distribution channel, the market is categorized into hospitals, retail pharmacies, and others. Hospitals segment was the highest revenue-generating segment in 2019 and is estimated to hold its dominant position during the forecast period. This is attributed to frequent visits to hospitals during treatment and the necessity for hospital stays. The retail pharmacies segment projected to grow at a lucrative CAGR during the forecast period.

Regional Insights

In 2019, North America was the highest revenue-generating region in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the well-developed healthcare expenditure, favourable reimbursement policies, growing healthcare expenditure, and increasing demand for advanced therapies. The Asia Pacific is projected to show the fastest CAGR over the forecast period owing to the rising prevalence of ALS, increasing R&D investment, developing healthcare infrastructure, and unmet medical needs in this region.

North America Amyotrophic Lateral Sclerosis Treatment Market Size (2017-2025), USD Million

North America Amyotrophic Lateral Sclerosis Treatment Market

Competitor Insights

Some of the key players in the amyotrophic lateral sclerosis treatment market are Otsuka Pharmaceutical Co., Ltd. (Japan); Biogen Inc. (U.S.); BrainStorm Therapeutics (U.S.); Mitsubishi Tanabe Pharma Corporation (Japan); AB Science (France); Corestem (South Korea); Biohaven Pharmaceutical (U.S.); F.Hoffmann-La Roche AG (Switzerland); Ionis Pharmaceuticals, Inc. (U.S.); and Sun Pharmaceutical (India). Leading companies adopt different strategies such as geographical expansion in developing markets, new product development, and strategic alliances to achieve a competitive edge.

 

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2025. The amyotrophic lateral sclerosis treatment market report is categorized into the following segments and subsegments:

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Treatment Type(Revenue, 2017-2025, USD Million)

  • Medication
  • Stem Cell Therapy
  • Others

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Distribution Channel (Revenue, 2017-2025, USD Million)

  • Hospitals
  • Retail Pharmacies
  • Others

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Region (Revenue, 2017-2025, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Amyotrophic Lateral Sclerosis Treatment Market Report:

Key Parameters Details
Data Availability 2017-2025
Historical Years 2017-2019
Base Year Considered 2019
Forecast Period 2019-2025
Company Profiles 10
Companies Considered (Across Value Chain) >25
Value Units Value in USD and CAGR in %
Market Segments Treatment and Distribution Channel
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, Australia, India, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Otsuka Pharmaceutical Co., Ltd. (Japan); Biogen Inc. (U.S.); BrainStorm Therapeutics (U.S.); Mitsubishi Tanabe Pharma Corporation (Japan); AB Science (France); Corestem (South Korea); Biohaven Pharmaceutical (U.S.); F.Hoffmann-La Roche AG (Switzerland); Ionis Pharmaceuticals, Inc. (U.S.); and Sun Pharmaceutical (India)
Custom Analysis Customization up to 60 analyst hours

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Treatment Type(Revenue, 2017-2025, USD Million)

  • Medication
  • Stem Cell Therapy
  • Others

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Distribution Channel (Revenue, 2017-2025, USD Million)

  • Hospitals
  • Retail Pharmacies
  • Others

Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Region (Revenue, 2017-2025, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
    1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
    1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Increasing Incidence of Amyotrophic Lateral Sclerosis
  3.1.2. Adoption of Advanced Technologies by Healthcare Professionals
  3.1.3. Rising R&D investment by Leading Companies
  3.1.4. Developing Healthcare Infrastructure in Emerging Economies
 3.2. Market Restraint Analysis
  3.2.1. Stringent Regulatory Protocols
  3.2.2. High Cost Of Implementation
  3.2.3. Lack of Experienced Professionals
 3.3. Market Opportunities
  3.3.1. Progressive Emerging Market For Healthcare Services
  3.3.2. Strategic Collaborations & Partnerships by Leading Market Players
  3.3.3. Increasing Awareness For Amyotrophic Lateral Sclerosis Treatment
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2017-2019)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2025)
6. Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast, by Treatment (2017-2025), USD Million
 6.1. Medication
 6.2. Stem Cell Therapy
 6.3. Others
7. Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast, By Distribution Channel (2017-2025), USD Million
 7.1. Hospitals
 7.2. Retail Pharmacies
 7.3. Others
8. Amyotrophic Lateral Sclerosis Treatment Market, Regional Analysis (2017-2025), USD Million
 8.1. North America
  8.1.1. Introduction
   8.1.1.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.1.1.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
   8.1.1.3. Market Size & Forecast, by Country (2017-2025), USD Million
  8.1.2. U.S.
   8.1.2.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.1.2.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.1.3. Canada
   8.1.3.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.1.3.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
 8.2. Europe
  8.2.1. Introduction
   8.2.1.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.1.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
   8.2.1.3. Market Size & Forecast, by Country (2017-2025), USD Million
  8.2.2. Germany
   8.2.2.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.2.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.3. UK
   8.2.3.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.3.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.4. France
   8.2.4.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.4.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.5. Spain
   8.2.5.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.5.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.6. Italy
   8.2.6.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.6.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.7. Russia
   8.2.7.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.7.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.2.8. Rest of Europe
   8.2.8.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.2.8.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
 8.3. Asia Pacific (APAC)
  8.3.1. Introduction
   8.3.1.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.1.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
   8.3.1.3. Market Size & Forecast, by Country (2017-2025), USD Million
  8.3.2. China
   8.3.2.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.2.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.3.3. Japan
   8.3.3.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.3.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.3.4. India
   8.3.4.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.4.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.3.5. Australia
   8.3.5.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.5.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.3.6. South Korea
   8.3.6.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.6.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.3.7. Rest of Asia Pacific
   8.3.7.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.3.7.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
 8.4. Latin America (LATAM)
  8.4.1. Introduction
   8.4.1.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.4.1.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
   8.4.1.3. Market Size & Forecast, by Country (2017-2025), USD Million
  8.4.2. Brazil
   8.4.2.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.4.2.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.4.3. Mexico
   8.4.3.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.4.3.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.4.4. Argentina
   8.4.4.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.4.4.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.4.5. Rest of LATAM
   8.4.5.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.4.5.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
 8.5. Middle East & Africa (MEA)
  8.5.1. Introduction
   8.5.1.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.5.1.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
   8.5.1.3. Market Size & Forecast, by Country (2017-2025), USD Million
  8.5.2. South Africa
   8.5.2.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.5.2.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.5.3. Saudi Arabia
   8.5.3.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.5.3.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
  8.5.4. Rest of MEA
   8.5.4.1. Market Size & Forecast, by Technology (2017-2025), USD Million
   8.5.4.2. Market Size & Forecast, by Distribution Channel (2017-2025), USD Million
9. Competitor Analysis
 9.1. Market Player Comparison
 9.2. Product-wise Player Mapping
 9.3. Region-wise Player Mapping
 9.4. Market Share Analysis
 9.5. Market Position Analysis
 9.6. Recent Development Analysis
10. Company Profiles
 10.1. Biogen Inc. (U.S.)
  10.1.1. Company Overview
  10.1.2. Company Financials
  10.1.3. Product Portfolio
  10.1.4. Recent Developments
 10.2. AB Science (France)
  10.2.1. Company Overview
  10.2.2. Company Financials
  10.2.3. Product Portfolio
  10.2.4. Recent Developments
 10.3. BrainStorm Therapeutics (U.S.)
  10.3.1. Company Overview
  10.3.2. Company Financials
  10.3.3. Product Portfolio
  10.3.4. Recent Developments
 10.4. Otsuka Pharmaceutical Co., Ltd. (Japan)
  10.4.1. Company Overview
  10.4.2. Company Financials
  10.4.3. Product Portfolio
  10.4.4. Recent Developments
 10.5. Mitsubishi Tanabe Pharma Corporation (Japan)
  10.5.1. Company Overview
  10.5.2. Company Financials
  10.5.3. Product Portfolio
  10.5.4. Recent Developments
 10.6. Biohaven Pharmaceutical (U.S.)
  10.6.1. Company Overview
  10.6.2. Company Financials
  10.6.3. Product Portfolio
  10.6.4. Recent Developments
 10.7. F. Hoffmann-La Roche AG (Switzerland)
  10.7.1. Company Overview
  10.7.2. Company Financials
  10.7.3. Product Portfolio
  10.7.4. Recent Developments
 10.8. Sun Pharmaceutical (India)
  10.8.1. Company Overview
  10.8.2. Company Financials
  10.8.3. Product Portfolio
  10.8.4. Recent Developments
 10.9. Ionis Pharmaceuticals, Inc. (U.S.)
  10.9.1. Company Overview
  10.9.2. Company Financials
  10.9.3. Product Portfolio
  10.9.4. Recent Developments
 10.10. Corestem (South Korea)
  10.10.1. Company Overview
  10.10.2. Company Financials
  10.10.3. Product Portfolio
  10.10.4. Recent Developments

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2019 to 2025 for Amyotrophic Lateral Sclerosis Treatment market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
  4. Which geographies have immense opportunities in different segments of the Amyotrophic Lateral Sclerosis Treatment market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Amyotrophic Lateral Sclerosis Treatment Market Analysis by Treatment (Stem Cell Transplant, Medication), by Distribution Channel (Hospitals, Retail Pharmacies) and by Region - Forecast to 2025